Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cancer Research

• Publication date

  1998-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 9679948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.

  1998cited by this paper
• Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.

  1998cited by this paper
• Poly(ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells.

  1998cited by this paper
• Expression of cyclooxygenase-2 in human gastric carcinoma.

  1997cited by this paper
• Superoxide Formation and Macrophage Resistance to Nitric Oxide-mediated Apoptosis*

  1997cited by this paper
• Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation.

  1997cited by this paper
• Cytosolic phospholipase A2, cyclo-oxygenases and arachidonate in human stomach tumours.

  1997cited by this paper
• The molecular basis for carcinogenesis in metaplastic columnar-lined esophagus.

  1997cited by this paper
• Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).

  1996cited by this paper
• Inducible nitric oxide synthase, nitrotyrosine, and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants.

  1996cited by this paper
• Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line.

  1996cited by this paper
• Suppression of Intestinal Polyposis in ApcΔ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2)

  1996cited by this paper
• Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease.

  1996cited by this paper
• Nitric oxide synthase activity and expression in human colorectal cancer.

  1996cited by this paper
• Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam.

  1996cited by this paper
• Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53.

  1996cited by this paper
• Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

  1996cited by this paper
• Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis.

  1996cited by this paper
• Nitric Oxide Inhibits Macrophage-Colony Stimulating Factor Gene Transcription in Vascular Endothelial Cells (*)

  1995cited by this paper
• Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2.

  1995cited by this paper
• Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis.

  1995cited by this paper
• Nitric oxide synthase activity in human breast cancer.

  1995cited by this paper
• Association of transforming growth factor alpha (TGFA) and its precursors with malignant change in Barrett's epithelium: Biological and clinical variables

  1995cited by this paper
• Oxidation and genotoxicity of fecapentaene-12 are potentiated by prostaglandin H synthase.

  1995cited by this paper
• Roles of nitric oxide in tumor growth.

  1995cited by this paper
• Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas.

  1994cited by this paper
• Nitric oxide synthase activity in human gynecological cancer.

  1994cited by this paper
• Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells.

  1994cited by this paper
• Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.

  1993cited by this paper
• Purification and cDNA sequence of an inducible nitric oxide synthase from a human tumor cell line.

  1993cited by this paper
• Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts.

  1993cited by this paper
• DNA damage and mutation in human cells exposed to nitric oxide in vitro.

  1992cited by this paper
• Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology.

  1992cited by this paper
• Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.

  1992cited by this paper
• Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort

  1992cited by this paper
• DNA deaminating ability and genotoxicity of nitric oxide and its progenitors.

  1991cited by this paper
• Nitric oxide: an endogenous modulator of leukocyte adhesion.

  1991cited by this paper
• Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines.

  1991cited by this paper
• Barrett's esophagus. Prevalence and incidence of adenocarcinoma.

  1991cited by this paper
• Progression to cancer in Barrett's esophagus is associated with genomic instability.

  1989cited by this paper
• Barrett's esophagus and adenocarcinoma.

  1987cited by this paper
• Barrett's esophagus and adenocarcinoma.

  1987cited by this paper
• Barrett's oesophagus.

  1987cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Chemoprevention in Barrett's Esophagus: An Updated Review.

  2025cites this paper
• Role of Lactobacillus Johnsonii in Gastroesophageal Reflux Disease in Obese Mice Following Sleeve Gastrectomy

  2025cites this paper
• The role of the esophageal and intestinal microbiome in gastroesophageal reflux disease: past, present, and future

  2025cites this paper
• The Role of Bile Acids in Pancreatic Cancer.

  2024cites this paper
• Revisiting Proton Pump Inhibitors as Chemoprophylaxis Against the Progression of Barrett’s Esophagus

  2023cites this paper
• Translating Molecular Biology Discoveries to Develop Targeted Cancer Interception in Barrett’s Esophagus

  2023cites this paper
• Bioactive Compounds and Signaling Pathways of Wolfiporia extensa in Suppressing Inflammatory Response by Network Pharmacology

  2023cites this paper
• Nitric oxide and inducible nitric oxide synthase levels in EE and NERD patients

  2022cites this paper
• Cross-talk between the microbiome and chronic inflammation in esophageal cancer: potential driver of oncogenesis

  2022cites this paper
• The Role of Microbiota in the Pathogenesis of Esophageal Adenocarcinoma

  2021cites this paper
• Statins, cancer, and oxidative stress

  2021cites this paper
• Inflammatory cytokines in the pathogenesis of cardiovascular disease and cancer

  2020cites this paper
• Effect of nonsteroidal anti-inflammatory drugs on Barrett's esophagus risk: a systematic review and meta-analysis.

  2020cites this paper
• Clinical Probes for ROS and Oxidative Stress

  2020cites this paper
• Mucosa-Associated Microbiota in Barrett's Esophagus, Dysplasia, and Esophageal Adenocarcinoma Differ Similarly Compared With Healthy Controls

  2020cites this paper
• Chemoprevention of esophageal adenocarcinoma

  2020cites this paper
• Simultaneous Determination of Docetaxel and Celecoxib in Porous Microparticles and Rat Plasma by Liquid-Liquid Extraction and HPLC with UV Detection: in vitro and in vivo Validation and Application.

  2020cites this paper
• Possible Effects of Capsaicin (Chili Pepper) on the Oral Health

  2020cites this paper
• Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor gamma system in experimental rat Barrett's esophagus.

  2020cites this paper
• Development of a prognostic signature for esophageal cancer based on nine immune related genes

  2020cites this paper
• Development of a prognostic model for esophageal cancer based on nine immune related genes

  2020cites this paper
• Risk Factors for Progression of Barrett’s Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma

  2020cites this paper
• Measuring Oxidants and Oxidative Stress in Biological Systems

  2020cites this paper
• Chitosan nanoparticles loaded with aspirin and 5-fluororacil enable synergistic antitumour activity through the modulation of NF-κB/COX-2 signalling pathway.

  2020cites this paper
• Effect of Proton Pump Inhibitor Therapy on NOX5, mPGES1 and iNOS expression in Barrett’s Esophagus

  2019cites this paper
• Epidemiology of Barrett Esophagus and Risk Factors for Progression

  2019cites this paper
• Isorhamnetin alleviates esophageal mucosal injury in a chronic model of reflux esophagitis.

  2019cites this paper
• The Esophageal Microbiome

  2019cites this paper
• The Cytotoxicity and Synergistic Potential of Aspirin and Aspirin Analogues Towards Oesophageal and Colorectal Cancer

  2019influential citation
• Chemoprevention of Esophageal Cancer

  2019cites this paper
• Aspirin acts in esophageal cancer: a brief review.

  2018cites this paper
• The Role of Molecular Biology in Diagnosis and Follow-Up of Barrett’s Esophagus

  2018cites this paper
• Evaluating the expression of cyclooxygenase-2 enzyme by immunohistochemistry in normal and tumoral tissue before and after neoadjuvant chemoradiotherapy in patients with esophageal cancer in Khorasan Province

  2018cites this paper
• Immunohistoc hemical localization of Inducible Nitric Oxide Synthase in Pleomorphic Adenoma of Salivary Gland: Correlation with Cyclooxygenase-2 and Tumor Proliferative Activity

  2018cites this paper
• Pro-Oxidant and Antioxidant Balance, Anthropometric Parameters, and Nutrient Intakes in Gastro-Esophageal Reflux Disease Patients

  2018cites this paper
• Proton Pump Inhibitors Do Not Reduce the Risk of Esophageal Adenocarcinoma in Patients with Barrett’s Esophagus: A Systematic Review and Meta-Analysis

  2017cites this paper
• 2 Gastroesophageal Reflux Disease : Molecular Predictors in Neoplastic Progression of Barrett ’ s Esophagus

  2017cites this paper
• Effects of Enteral Immunonutrition in Esophageal Cancer

  2017cites this paper
• Gastric Mucosal Injury and Oxidative Stress

  2017cites this paper
• Chemopreventive Strategies for Inflammation-Related Carcinogenesis: Current Status and Future Direction

  2017cites this paper
• Inducible Nitric Oxide Synthase in the Carcinogenesis of Gastrointestinal Cancers

  2017cites this paper
• Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis.

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Barrett ’ s esophagus and esophageal adenocarcinoma : from molecular pathogenesis to novel therapeutic targets

  2017cites this paper
• A nonrandomized trial of vitamin D supplementation for Barrett’s esophagus

  2017cites this paper
• Status of Salivary Nitric Oxide Levels and Buccal Epithelial Cell DNA Damage in Potentially Malignant Disorders – A Biochemical Study

  2017cites this paper
• Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the ApcMin/+ mouse model of intestinal tumorigenesis

  2017cites this paper
• Downregulation of NMI promotes tumor growth and predicts poor prognosis in human lung adenocarcinomas

  2017cites this paper
• Redox signaling in the gastrointestinal tract.

  2017cites this paper
• Adenocarcinoma of the Esophagus : Risk Factors and Prevention

  2017cites this paper
• Lupeol evokes anticancer effects in oral squamous cell carcinoma by inhibiting oncogenic EGFR pathway

  2016cites this paper
• DNA damage induced by occupational and environmental exposure to miscellaneous chemicals.

  2016cites this paper
• Evaluation of iNOS Expression in Esophageal Cancer Patients

  2016cites this paper
• Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesis.

  2016cites this paper
• A Comprehensive and Contemporary Review for Pathologists

  2016cites this paper
• The Role of Drugs and Nutrition in the Prevention of Esophageal Adenocarcinoma Associated with Barrett’s Esophagus

  2016cites this paper
• DNA damage induced by occupational and environmental exposure to miscellaneous chemicals.

  2016cites this paper
• Chemoprevention of Barrett’s Esophagus and Adenocarcinoma

  2016cites this paper
• Biological properties of Alsidium corallinum and its potential protective effects against damage caused by potassium bromate in the mouse liver

  2016cites this paper
• Role of Macrophages in the Development of Castration-Resistant Prostate Cancer

  2016cites this paper
• Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma.

  2016cites this paper
• Effects of Non-Steroidal Anti-Inflammatory Drugs on the Gastrointestinal and Cardiovascular System

  2016cites this paper
• Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett’s Esophagus

  2016cites this paper
• Chemoprevention in Barrett's oesophagus.

  2015cites this paper
• A fast and selective two-photon phosphorescent probe for the imaging of nitric oxide in mitochondria.

  2015cites this paper
• Pyrido[1,2-a]pyrimidinium ions--a novel bridgehead nitrogen heterocycles: synthesis, characterisation, and elucidation of DNA binding and cell imaging properties.

  2015cites this paper
• Formulation and optimization of celecoxib-loaded PLGA nanoparticles by the Taguchi design and their in vitro cytotoxicity for lung cancer therapy

  2015cites this paper
• Emerging optical methods for surveillance of Barrett's oesophagus

  2015cites this paper
• Biological Evaluation, Isolation and Characterization of Compounds from Fagonia cretica L.

  2015cites this paper
• Inflammatory and non-inflammatory roles for Toll-like receptors in gastrointestinal cancer.

  2015cites this paper
• Esophageal Adenocarcinoma: The Influence of Medications Used to Treat Comorbidities on Cancer Prognosis.

  2015cites this paper
• A multi-targeted approach to suppress tumor-promoting inflammation.

  2015cites this paper
• Correction: Pyrido[1,2-a]pyrimidinium ions - a novel bridgehead nitrogen heterocycles: synthesis, characterisation, and elucidation of DNA binding and cell imaging properties.

  2015cites this paper
• Medical Prevention of Barrett’s Esophagus: Effects of Statins, Aspirin, Non-aspirin NSAIDs, Calcium, and Multivitamins

  2015cites this paper
• Title Increased expression of cyclooxygenase-2 in first-degree relatives of gastric cancer patients

  2015cites this paper
• Potency of non-steroidal anti-inflammatory drugs in chemotherapy (Review)

  2015cites this paper
• COX2- Inhibitors and Their Role in Cancer Prevention and Treatment

  2015cites this paper
• Potency of non-steroidal anti-inflammatory drugs in chemotherapy.

  2015cites this paper
• NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case–control study

  2015influential citation
• Towards an integrated understanding of low-dose chemical exposures in the development of human cancer

  2015cites this paper
• Cyclooxygenase-2 expression is associated with elevated aspartate aminotransferase level in hepatocellular carcinoma.

  2015cites this paper
• Quantitative measurement of m-RNA levels to assess expression of cyclooxygenase-II, inducible nitric oxide synthase and 12-lipoxygenase genes in middle ear cholesteatoma

  2014cites this paper
• Nitric Oxide Synthase: Non-Canonical Expression Patterns

  2014cites this paper
• Guggulsterone, a Plant-Derived Inhibitor of NF-TB, Suppresses CDX2 and COX-2 Expression and Reduces the Viability of Esophageal Adenocarcinoma Cells

  2014cites this paper
• Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.

  2014cites this paper
• Microbiome, innate immunity, and esophageal adenocarcinoma.

  2014cites this paper
• Effect of aspirin treatment on the prevention of esophageal adenocarcinoma in a rat experimental model.

  2014cites this paper
• Expression of Cox 2 in Gastric Mucosa of Patients with Gastric Carcinoma and Its Correlation with the Disease Progression

  2014cites this paper
• Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus.

  2014cites this paper
• Operable gastro-oesophageal junctional adenocarcinoma: Where to next?

  2014cites this paper
• Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: current state-of-the science.

  2014cites this paper
• The Role of PGE2 and its Corresponding Receptors (Ep1-4) in Oesophageal Carcinogenesis: Novel Therapeutics for Chemoprevention and/or Intervention

  2014cites this paper
• Cyclo-oxygenase-2 expression in oral squamous cell carcinoma.

  2014cites this paper
• Protective Effects of Chlorogenic Acid against Experimental Reflux Esophagitis in Rats

  2014cites this paper
• High levels of γ-H2AX foci and cell membrane oxidation in adolescents with type 1 diabetes.

  2014cites this paper
• Involvement of luminal nitric oxide in the pathogenesis of the gastroesophageal reflux disease spectrum

  2014cites this paper
• Role of chemoprophylaxis with either NSAIDs or statins in patients with Barrett's esophagus.

  2014cites this paper
• Synthesis and chemical and biological comparison of nitroxyl- and nitric oxide-releasing diazeniumdiolate-based aspirin derivatives.

  2013cites this paper
• Anticancer and immunostimulatory role of encapsulated tumor antigen containing cobalt oxide nanoparticles

  2013cites this paper
• Oxidative Stress in the Carcinogenicity of Chemical Carcinogens

  2013cites this paper
• Chronic inflammation-derived nitric oxide causes conversion of human colonic adenoma cells into adenocarcinoma cells.

  2013cites this paper